Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis
Journal of Ophthalmic Inflammation and Infection volume 4, Article number: 10 (2014)
Polymerase chain reaction (PCR) assay can be a useful method for definitive diagnosis in paucibacillary infections such as ocular tuberculosis (TB). In this study, we have evaluated factors affecting PCR outcomes in patients with clinically suspected ocular TB. Patients with clinically suspected ocular TB were investigated by PCR of aqueous or vitreous samples. Three control groups were also tested: group 1 included culture-proven non-tuberculous endophthalmitis, group 2 culture-negative non-tuberculous endophthalmitis, and group 3 patients undergoing surgery for uncomplicated cataract. PCR targeted one or more of following targets: IS6110, MPB64, and protein b genes of Mycobacterium tuberculosis complex. Multiple regression analysis (5% level of significance) was done to evaluate the associations between positive PCR outcome and laterality of disease, tuberculin skin test (TST)/interferon-gamma release assay (IGRA), chest radiography, and type of sample (aqueous or vitreous). The main outcome measures were positive PCR by one or more gene targets, and factors influencing positive PCR outcomes.
All 114 samples were tested for MPB64, 110 for protein b, and 88 for IS6110. MPB64 was positive in 70.2% (n = 80) of tested samples, protein b in 40.0% (n = 44), and IS6110 in only 9.1% (n = 8). DNA sequencing of amplicons from four randomly chosen PCR reactions showed homology for M. tuberculosis complex. Of the 80 PCR-positive patients, 71 completed a full course of antitubercular therapy, of which 65 patients (91.5%) had complete resolution of inflammation at final follow-up. Among controls, 12.5% (3 out of 24) in group 1 and 18.7% (6 out of 32) in group 2 also tested positive by PCR. No PCR-positive outcome was observed in control group 3 (n = 25). Multiple regression analysis revealed significant association of positive PCR outcome with bilateral presentation, but not with a positive TST/IGRA, chest radiography, or type of sample (aqueous/vitreous) used.
Careful selection of gene targets can yield high PCR positivity in clinically suspected ocular TB. Bilateral disease presentation but not any evidence of latent systemic TB influences PCR outcomes. False-positive results may be seen in ocular inflammation unrelated to ocular TB.
Ocular tuberculosis (TB) is the most common cause of infectious uveitis in high endemic countries . However, the paucibacillary nature of this disease limits its detection by conventional techniques like smear microscopy and culture. Nucleic acid amplification tests (NAATs) like polymerase chain reaction (PCR) can therefore be a useful alternative for definitive diagnosis of this condition .
PCR-based diagnosis of any form of extrapulmonary TB is challenging due to the paucibacillary nature of specimens, lack of adequate sample volumes, non-uniform distribution of bacteria in such specimens, presence of PCR inhibitors, and lack of proper gold standard for evaluation of its diagnostic potential . Past attempts at PCR for ocular TB have yielded low positivity rates ranging from 33.3% for retinal vasculitis to 66.6% for panuveitis . Not surprisingly, PCR has not gained popularity in the diagnosis of ocular TB despite being first described nearly two decades ago . As a result, much of clinical practice as well as existing literature is based on presumed diagnosis of ocular TB. Such presumed diagnosis may potentially lead to both under- and overdiagnosis of the condition, exposing the patient to unprotected steroid therapy or toxic antitubercular therapy (ATT), respectively.
The initial PCR studies for ocular TB were based on single-target PCR, typically with IS6110 as the gene target [4, 5]. About 2 years ago, multi-target PCR was shown to have high specificity (100%) and sensitivity (73.68%) in a series of 19 patients with suspected ocular TB (Sharma K et al., Novel multiplex polymerase chain reaction for diagnosis of intraocular tuberculosis. Poster at: AAO Annual Meeting, Orlando, 2011). The authors had used three gene targets (IS6110, MPB64, and protein b) since the commonly used target, IS6110, was reported to be absent in up to 11% of patients in certain populations . The encouraging results of this report prompted us to initiate routine use of PCR in the diagnosis of ocular TB. The present study is a retrospective analysis of the PCR outcomes, clinical characteristics, and results of treatment in patients with clinically suspected ocular TB, who were investigated with PCR at our institute. We have attempted to determine the factors that could have influenced PCR outcomes in our patients.
The study was approved by the institutional review board of L V Prasad Eye Institute and adhered to the tenets of the Declaration of Helsinki. We included all patients, clinically suspected to have ocular TB and investigated with PCR, between November 2011 and February 2013 at our institute. The clinical diagnosis was based on the presence of any one or more of the following - granulomatous anterior uveitis, intermediate uveitis, retinal vasculitis, serpiginous-like choroiditis, focal or multifocal choroiditis, and panuveitis - and exclusion of other uveitic entities, which could cause similar clinical presentation. Grades of inflammation and criteria for response to treatment were based on Standardization of Uveitis Nomenclature (SUN) working group recommendations . All patients received tuberculin skin test (TST) and/or interferon-gamma release assay (IGRA) and at least one form of chest radiography (plain X-ray/high-resolution computed tomography). Positive TST was defined as induration ≥10 mm after subcutaneous injection of 5 tuberculin units in immune-competent patients. Physician referral was done to rule out any other focus (pulmonary/extrapulmonary) of TB.
We included patients who had anterior chamber cells, along with clinical signs suggestive of ocular TB. Around 150 to 200 μl of aqueous humor was collected by anterior chamber paracentesis under strict aseptic precautions. In selected patients (n = 20), like those receiving therapeutic vitrectomy for non-resolving intermediate uveitis, vitreous samples were used for PCR.
DNA was extracted from all the samples using QIAamp DNA mini kit (Qiagen, Hilden, Germany) tissue protocol, with the following modifications: an enzymatic digestion step with 30 mg/ml lysozyme added to the tissue lysis buffer and incubated at 37°C for 1 h followed by adding 20 μl of proteinase K and 200 μl of lysis buffer and incubated at 56°C for 1 h. DNA was purified as per manufacturer's recommendations through a minispin column, and 50 μl of elution buffer was used to elute the DNA. Extracted DNA was stored at -20°C until PCR testing.
Multi-target PCR targeting IS6110, MPB64, and protein b in Mycobacterium tuberculosis complex was standardized as described previously . Details of the primer sequences were as mentioned in Table 1. Amplification was performed in a 50-μl reaction mixture including 10 pmol of each primer, 200 μM each deoxynucleoside triphosphate, 1.5 mM MgCl2, 10× PCR buffer without MgCl2, 1 unit of Taq DNA polymerase, and 10 μl of template. The PCR cycles consisted of an initial denaturation step at 94°C for 5 min, 40 cycles of denaturation at 94°C for 1 min, annealing at 65°C for 20 s with an extension at 72°C for 30 s, and a final extension at 72°C for another 10 min. Double autoclaved Milli-Q water (Millipore Co., Billerica, MA, USA) was used as negative control, and M. tuberculosis H37Rv DNA was used as a positive control. Both controls were included in each PCR run. After PCR, the amplified products were electrophoretically resolved in an ethidium bromide-stained 1.5% agarose gels in 1× Tris acetate EDTA buffer and visualized under UV transillumination. Care was taken to avoid contamination by doing all procedures like isolation of DNA, PCR master mixture preparation, addition of template, PCR, and gel electrophoresis in separate rooms.
Analytical sensitivity and specificity
The analytical sensitivity of PCR was determined using different concentrations of M. tuberculosis H37Rv DNA and was found to be 250 fg per reaction (50 copies/reaction). The analytical specificity of PCR was verified using DNA from different microorganisms (bacterial, fungal, viral, and parasitic) and human leukocytic DNA. No amplification was observed with DNA other than M. tuberculosis H37Rv.
Detection limit for individual primers in multi-target PCR assay
Aqueous humor from patients undergoing cataract surgery was spiked with 106 colony forming units (CFU) of M. tuberculosis per 100 μl of sample. It was then diluted to achieve 105, 104, 103, 102, 10, and 5 CFU per 100 μl of sample, respectively. DNA was extracted from each of the samples, and multi-target PCR was performed for them. This also helped in ruling out PCR inhibition in ocular samples.
Amplicons from four PCR reactions were randomly chosen for sequencing to demonstrate homology with M. tuberculosis complex. Sequencing was performed with fluorescence-labeled dideoxynucleotide terminators using an ABI 3130 Xl automated sequencer, following the manufacturer's instructions (PE Applied Biosystems, Foster City, CA, USA). The sequences were analyzed and identified using the MEGABLAST search program of the GenBank database.
The study had three control groups. Group 1 had 24 vitreous samples collected from patients with culture-proven non-tuberculous endophthalmitis (disease controls), group 2 had 32 vitreous samples from patients with culture-negative endophthalmitis (clinically non-tuberculous, also disease controls), and group 3 had 25 aqueous samples collected from patents who underwent cataract surgery (negative controls).
Descriptive statistics was used to calculate PCR positivity rate in cases and controls. Multiple regression analysis was used to assess association between positive PCR outcome and laterality of disease, TST/IGRA, chest radiograph, and duration of current attack of uveitis (InStat statistical software version Win 3.0x, GraphPad Software, Inc. CA, USA).
A total of 114 ocular fluid samples from 114 subjects with clinically suspected ocular TB were tested, and positive PCR outcomes were obtained in 70.2% (n = 80) patients. The baseline characteristics of these patients are given in Table 2. Majority of the tested samples (82.5%; n = 94) were aqueous taps, while the remainder consisted of vitreous samples. The most common clinical presentation among our patients was retinal vasculitis (33.3%; n = 38) followed by panuveitis (21.9%; n = 25). Patients with retinal vasculitis, panuveitis, or anterior uveitis had a higher PCR positivity rate, as compared to intermediate uveitis and serpiginous-like choroiditis (data not shown). Significantly, nearly half the total patients (45.6%; n = 52) did not have any immunological evidence of previous tuberculous infection (tuberculin test/IGRA), while nearly four fifths (79.8%; n = 91) did not have any radiological evidence of healed TB. Similar proportions were noted in the PCR-positive group: 43.8% (n = 35) had negative tuberculin test/IGRA, and 78.7% (n = 67) had normal chest radiograms. None of the patients had any evidence of active systemic TB, possibly because only such patients were selected for the PCR test.
Of the total 114 samples, the initial 88 samples were tested by all three targets (IS6110, MPB64, and protein b) and 67 (76.1%) were found to be positive. Of these, MPB64 was positive in all 67 samples, protein b in 41 samples, and IS6110 in 8 (9.1%) samples. All IS6110 positives were also positive by MPB64 and protein b. Based on these results, we discontinued using the IS6110 gene target, and the next 22 samples were tested by PCR targeting MPB64 and protein b only and 9 were found to be positive. Again, MPB64 was positive in all nine samples and protein b in three of these nine samples. The last four samples included in this study were tested only with MPB64, and all were positive.
The detection limit of MPB64 primers were found to be 10 CFU/100 μl, while that for protein b and IS6110 were 102 CFU/100 μl (the band for IS6110 appearing fainter than protein b at this dilution, Figure 1). No amplification was observed at 5 CFU dilution. DNA sequencing of the four PCR amplicons that were tested showed homology with the M. tuberculosis complex.
Of the 80 patients with positive TB PCR outcomes, 77 agreed for treatment with anti-TB therapy (ATT) and adjunctive corticosteroids, and 71 completed a 6-month course of ATT. Of these 71 patients, 65 (91.5%) had resolved inflammation at final follow-up, while the rest (n = 6; 8.5%) had persistent or recurrent episodes of inflammation.
The PCR outcomes in the control groups are detailed in Table 3. In group 1 (culture-positive endophthalmitis), 3 of 24 samples (12.5%) were positive for M. tuberculosis complex DNA by multi-target PCR. In group 2 (culture-negative endophthalmitis, n = 32), six (18.75%) had positive PCR outcomes. One PCR-positive sample in this group was also smear positive for fungus. No PCR amplification was observed in group 3 (cataract, n = 25).
On multivariate regression analysis, only bilateral presentation of uveitis appeared to favor a positive PCR outcome in our study (Table 4). Positive TST/IGRA or positive chest radiography did not appear to influence the PCR outcome. Also, there was no difference in PCR outcomes between using aqueous or vitreous samples.
PCR offers the only opportunity for definitive diagnosis in majority of cases of ocular TB. Yet, its application in clinical practice has been limited mostly due to poor positivity rates. In this study, we have reported high PCR positivity (70.6%) in ocular TB, with recently introduced modifications in the PCR technique. Our PCR outcomes were validated by DNA sequencing of the PCR amplicons and beneficial effect of ATT in majority (91.5%) of the PCR-positive patients. Further, we have analyzed the factors influencing the PCR outcomes in our ocular TB patients.
Evidently, the key factor behind the high PCR positivity (70.6%) in our patients was the selection of gene targets. Initially, we used multi-target PCR with three different gene targets but later narrowed down to a single target - MPB64 - since it was present in all PCR-positive samples. In contrast, the traditionally used gene target IS6110 was found in only 9.1% of the samples. This unexpected result could be attributed to two factors: differences in primer efficiency in multi-target PCR conditions and regional variations in mycobacterial strains and, thereby, gene targets. As shown in Figure 1, the bands for protein b and IS6110 were barely visible at a dilution of 102 CFU/100 μl of the sample, while that for MPB64 was significantly brighter even at 10 CFU/100 μl dilution. Since the template for this PCR assay (Figure 1) was obtained from a known concentration and strain of M. tuberculosis, such difference in detection limits for individual primers would have resulted from the difference in primer efficiency in multi-target PCR conditions. Thus, IS6110 and/or protein b may not have been detected despite being present in our samples. Although these two primers differ in detection limit from MPB64, only by a factor of 10 (one log unit), such a difference can be significant in extreme paucibacillary conditions such as ocular TB. In a recent report from north India that used the same primers and PCR conditions, two of seven samples were positive only for MPB64 though they also had one sample positive only for IS6110. Interestingly, such gross difference in MPB64 and IS6110 positivity was not seen when the same multi-target PCR assay was performed in TB meningitis patients . We speculate that higher bacillary load in TB meningitis as compared to ocular TB could have accounted for this variation.
There is also a possibility of M. tuberculosis strain variations in our part of the country, or in infections affecting the eye, such that IS6110 may have been absent or present in reduced copy numbers in our samples. An earlier study from south India had highlighted the significantly higher sensitivity for MPB64 than IS6110 in PCR on epiretinal membranes from Eales' disease patients . Based on these results, we propose that MPB64-based uniplex PCR is sufficient for diagnosis of majority of ocular TB cases in India. Similar ‘region-specific’ PCR can be planned for other geographic regions based on positivity of specific gene targets. For example, in the USA, IS6110 is absent in only 1% of M. tuberculosis strains and can thus be an ideal gene target for PCR .
We also tried to investigate the role of other possible factors influencing PCR outcomes by multiple regression analysis. We found that only bilateral disease presentation favored a positive PCR outcome, although infectious ocular diseases are typically associated with unilateral presentation. Interestingly, a recent report noted bilateral presentation in about 63% of 105 patients with tubercular multifocal serpiginoid choroiditis . More importantly, positive immunological tests (TST/QFT) or chest radiography did not influence PCR outcomes in our study. This correlates with an earlier report of histopathologically proven ocular TB, in which 40% of patients had negative TST and 57% had normal chest films . Also, reactivation of tuberculosis at extrapulmonary sites is known to occur without active pulmonary TB, in 15% cases .
Besides the above factors, we believe that the diagnostic yield of PCR in our study was improved by our case selection, based on previously described ocular signs . A recent systematic review on the role of NAATs in smear-negative pulmonary TB showed that a positive NAAT was found most useful in ruling in pulmonary TB when the pretest probability was at least intermediate (between 30% and 40%) . However, a negative NAAT in this group was not useful in ruling out the disease. If extrapolated to ocular TB, a positive PCR if considered with clinical signs and other investigations can help in reaching the final diagnosis, though a negative PCR would not rule out the disease.
We could not determine the diagnostic sensitivity and specificity of PCR in our study due to lack of an appropriate gold standard (culture/microscopy). Previous studies have considered clinical diagnosis as the ‘gold standard’ but that remains highly debatable [9, 10]. There is another important caveat that needs to be addressed for wider acceptance of diagnostic PCR, especially in TB-endemic countries. As seen in our control groups 1 and 2, a significant number of patients with ocular inflammation unrelated to TB may have positive PCR for TB. All except one of the PCR-positive patients in control groups had either postoperative or posttraumatic endophthalmitis. The only PCR-positive endogenous endophthalmitis patient was culture positive for Aspergillus flavus. Hence, we are convinced that all the positive PCR outcomes in the control groups represented false-positive outcomes. In the earlier report from north India, none of the six controls with intraocular inflammation unrelated to TB had positive PCR for TB . Though we had a much larger control group with intraocular inflammation (n = 56), the high incidence of false-positive outcomes (16.1%) in this group needs further explanation. It is known that M. tuberculosis can persist in several cell types and sites in the body, without any lung involvement, especially in highly endemic populations [17, 18]. Thus, it is possible that inflammatory cells present in aqueous or vitreous sample may have harbored the bacilli or its DNA, giving rise to false-positive results. Future studies with reverse transcriptase PCR for mycobacterial mRNA may help in identifying viable bacilli in the eye, thereby providing a more definitive diagnosis .
To conclude, careful selection of gene targets can help us achieve high PCR positivity in clinically suspected ocular TB patients. Immunological or radiological evidence of latent TB does not influence the PCR outcome. However, false-positive PCR in patients with non-TB ocular inflammation remains a challenge that needs to be resolved.
NC participated in the project during her fellowship at L V Prasad Eye Institute, Bhubaneswar. PKB and SS were also at L V Prasad Eye Institute, Bhubaneswar, during the period of study.
Singh R, Gupta V, Gupta A: Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 2004, 52: 121–125.
Gupta V, Gupta A, Rao NA: Intra-ocular tuberculosis – an update. Surv Ophthalmol 2007, 52: 561–587. 10.1016/j.survophthal.2007.08.015
Mehta PK, Raj A, Singh N, Khuller GK: Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol 2012, 66: 20–36. 10.1111/j.1574-695X.2012.00987.x
Arora SK, Gupta V, Gupta A, Bambery P, Kapoor GS, Sehgal S: Diagnostic efficacy of polymerase chain reaction in granulomatous uveitis. Tuber Lung Dis 1999, 79: 229–233. 10.1054/tuld.1999.0210
Kotake S, Kimura K, Yoshikawa K, Sasamoto Y, Matsuda A, Nishikawa T, Fujii N, Matsuda H: Polymerase chain reaction for the detection of Mycobacterium tuberculosis in ocular tuberculosis. Am J Ophthalmol 1994, 117: 805–806.
Chauhan DS, Sharma VD, Prashar D, Chauhan A, Singh D, Singh HB, Das R, Aggarwal BM, Malhotra B, Jain A, Sharma M, Kataria VK, Aggarwal JK, Hanif M, Shahani A, Katoch VM: Molecular typing of Mycobacterium tuberculosis isolates from different parts of India based on IS6110 element polymorphism using RFLP analysis. Indian J Med Res 2007, 125: 577–581.
Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005, 140: 509–516.
Kusum S, Aman S, Pallab R, Kumar SS, Manish M, Sudesh P, Subhash V, Meera S: Multiplex PCR for rapid diagnosis of tuberculous meningitis. J Neurol 2011, 258: 1781–1787. 10.1007/s00415-011-6010-4
Sharma K, Gupta V, Bansal R, Sharma A, Sharma M, Gupta A: Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect 2013, 3: 25. 10.1186/1869-5760-3-25
Madhavan HN, Therese KL, Gunisha P, Jayanthi U, Biswas J: Polymerase chain reaction in detection of Mycobacterium tuberculosis DNA in epiretinal membrane in Eales' disease. Invest Ophthalmol Vis Sci 2000, 41: 822–825.
Agasino CB, Ponce de Leon A, Jasmer RM, Small PM: Epidemiology of Mycobacterium tuberculosis strains in San Francisco that do not contain IS6110. Int J Tuberc Lung Dis 1998, 2: 518–520.
Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P: Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology 2012, 119: 2334–2342. 10.1016/j.ophtha.2012.05.034
Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M: Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology 2011, 118: 772–777. 10.1016/j.ophtha.2010.08.011
Farer L, Lowell A, Meador M: Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979, 109: 205–217.
Gupta A, Bansal R, Gupta V, Sharma A, Bambery P: Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010, 149: 562–570. 10.1016/j.ajo.2009.11.020
Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A: A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007, 11: 151–153.
Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GA, Bjune G: Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356: 2133–2138. 10.1016/S0140-6736(00)03493-0
Barrios-Payán J, Saqui-Salces M, Jeyanathan M, Alcántara-Vazquez A, Castañon-Arreola M, Rook G, Hernandez-Pando R: Extrapulmonary locations of Mycobacterium tuberculosis DNA during latent infection. J Infect Dis 2012, 206: 1194–1205. 10.1093/infdis/jis381
Van Gelder RN: Ocular pathogens of the twenty-first century. Am J Ophthalmol 2010, 150: 595–597. 10.1016/j.ajo.2010.08.020
We gratefully acknowledge the support of Hyderabad Eye Research Foundation, Hyderabad, India. We would also like to thank Dr. Mamatha Reddy Muppidi (Scientist, L V Prasad Eye Institute, Bhubaneswar) for her help in data analysis.
The authors declare that they have no competing interests.
SB conceived, designed, analyzed and interpreted the data, and drafted and revised the manuscript. PKB performed the data acquisition, analysis, and interpretation, and drafted and revised the manuscript. RRM performed the data acquisition, analysis, and interpretation, and revised the manuscript. NM performed the data analysis and interpretation, and revised the manuscript. NC, MRB, TRP, and SRP performed the data acquisition and revised the manuscript. SS performed the data analysis and interpretation and revised the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Balne, P.K., Modi, R.R., Choudhury, N. et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthal Inflamm Infect 4, 10 (2014). https://doi.org/10.1186/1869-5760-4-10
- Ocular tuberculosis
- Polymerase chain reaction